^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    3D Predict™ Glioma

    Company:
    Kiyatec
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    3D Predict is the leading ex vivo 3D cell culture functional precision oncology platform with published, peer-reviewed evidence correlating prospective therapeutic response prediction results to actual patient outcomes.
    Cancer:
    Glioma
    Method:
    Functional tumor profiling